ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.86−0.44 (-5.30%)
Close on Nov 17, 2026Market cap $251.95MP/E –Yield –
ClearPoint Neuro operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
ClearPoint Neuro's operating cash flow for the twelve months ending Sep 30, 2026 was -$47.14M. For fiscal 2025 it was -$23.90M. The highest annual figure on record is -$2.85M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$23.90M | – |
| FY2024 | Dec 31, 2024 | -$8.95M | – |
| FY2023 | Dec 31, 2023 | -$13.72M | – |
| FY2022 | Dec 31, 2022 | -$16.17M | – |
| FY2021 | Dec 31, 2021 | -$12.70M | – |
| FY2020 | Dec 31, 2020 | -$7.81M | – |
| FY2019 | Dec 31, 2019 | -$2.85M | – |
| FY2018 | Dec 31, 2018 | -$4.63M | – |
| FY2017 | Dec 31, 2017 | -$5.99M | – |
| FY2016 | Dec 31, 2016 | -$5.82M | – |
| FY2015 | Dec 31, 2015 | -$8.64M | – |
| FY2014 | Dec 31, 2014 | -$7.25M | – |
| FY2013 | Dec 31, 2013 | -$7.78M | – |
| FY2012 | Dec 31, 2012 | -$7.43M | – |
| FY2011 | Dec 31, 2011 | -$6.24M | – |
| FY2010 | Dec 31, 2010 | -$7.71M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$20.10M | – |
| Q2 FY2026 | Jun 30, 2026 | -$7.02M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.97M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.06M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.55M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.24M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.20M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.67M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.84M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.17M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.80M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.08M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.68M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.07M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.85M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.98M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.27M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.55M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.30M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.72M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.13M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.40M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.37M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.71M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.33M | – |
| Q4 FY2019 | Dec 31, 2019 | -$466.30K | – |
| Q3 FY2019 | Sep 30, 2019 | -$964.14K | – |
| Q2 FY2019 | Jun 30, 2019 | -$810.11K | – |
| Q1 FY2019 | Mar 31, 2019 | -$609.46K | – |
| Q4 FY2018 | Dec 31, 2018 | -$582.38K | – |
| Q3 FY2018 | Sep 30, 2018 | -$975.27K | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.11M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.96M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.75M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.68M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.22M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.35M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.11M | – |
See a number that looks wrong?